Tirzepatide vs Ozempic Price: What You'll Actually Pay

Tirzepatide and Ozempic cost roughly the same on paper, with both sitting near $1,000 per month at list price, but the amount you personally pay is often very different. Ozempic is a semaglutide product approved only for type 2 diabetes, while tirzepatide is sold as Mounjaro for diabetes and Zepbound for weight loss. That difference in FDA labeling drives most of the real-world price gap at the pharmacy counter.

Tirzepatide vs Ozempic Price at a Glance

List price is the published price a manufacturer sets, and almost nobody pays it without a discount program. Cash-pay prices are what you pay when you skip insurance and use a manufacturer's direct pharmacy instead.

Brand	Active ingredient	Typical list price per month	Typical cash-pay price	FDA-approved use
Ozempic	semaglutide	about $997	about $499	Type 2 diabetes
Wegovy	semaglutide	about $1,349	about $499	Chronic weight management
Mounjaro	tirzepatide	about $1,070	about $499	Type 2 diabetes
Zepbound	tirzepatide	about $1,060	about $349–$499	Chronic weight management

These figures shift several times a year, so treat them as ballparks rather than fixed rates. Both Novo Nordisk and Eli Lilly have cut cash-pay pricing and expanded their direct-to-patient pharmacies since 2024. Pharmacy benefit managers also negotiate their own confidential rates, which is why two neighbors on identical plans can see different numbers.

Why Ozempic and Tirzepatide Are Not Priced the Same Way

Ozempic competes with Mounjaro in the type 2 diabetes market, while Wegovy competes with Zepbound in the obesity market. Insurers cover diabetes indications far more readily, because those uses have clear diagnostic criteria and long-running cost-benefit data behind them. Weight-loss indications are covered more selectively and often come with stricter rules.

If your goal is weight loss rather than blood sugar control, the semaglutide vs tirzepatide weight loss comparison is the one that actually matters for your wallet, since you would be pricing Wegovy against Zepbound instead of Ozempic against Mounjaro. Clinical trials like STEP and SURMOUNT drive the ongoing tirzepatide vs semaglutide which is better debate, but better average results do not translate into a lower price for any individual patient.

Both drugs are brand-only products with patent protection that runs well into the 2030s. That means no low-cost copy is coming soon, and pricing will continue to be shaped by manufacturer programs rather than generic competition.

What Actually Changes Your Monthly Cost

Two people taking the same drug can pay $25 and $1,000 in the same month. The variables below explain nearly every difference.

• Insurance type. Commercial plans, marketplace plans, Medicare Part D, and Medicaid all treat these drugs differently. Medicare Part D generally excludes drugs used purely for weight loss.
• Formulary tier. A specialty-tier placement can mean 25% to 50% coinsurance instead of a flat copay.
• Prior authorization. Most plans want a diagnosis code, a documented BMI or A1C, and sometimes a step-therapy trial of a preferred drug first.
• Deductible status. Early in the plan year, you may pay the full negotiated price until your deductible is met.
• Dose strength. Higher doses cost more, especially in cash-pay vial programs.
• Pharmacy choice. The same prescription can differ by $100 or more between a retail chain, a mail-order service, and a manufacturer's direct pharmacy.

Dose, Pen, and Vial Pricing Explained

Ozempic pens are priced by strength

Ozempic comes in 0.25 mg, 0.5 mg, 1 mg, and 2 mg pens. The 2 mg pen typically costs more per fill than the lower strengths, and a single 3 mL pen can last anywhere from four to eight weeks depending on the dose you inject. That overlap is why a monthly estimate sometimes looks lower or higher than expected.

Zepbound vials and Mounjaro pens are priced by dose

Eli Lilly sells single-dose Zepbound vials through its direct pharmacy at tiered prices, with the starting 2.5 mg dose costing the least and higher doses costing more. Mounjaro is sold as prefilled pens, and its cash pricing follows a similar tiered pattern. A patient who titrates up to 15 mg of tirzepatide will pay a different amount than one who stays at 5 mg.

Cash-Pay Programs, Compounding, and Generics

There is no tirzepatide generic price to compare yet, because no generic version has been approved in the United States. Any website advertising generic tirzepatide is selling something else, usually a research chemical or an unapproved compounded product with no verified potency or sterility testing.

Compounded semaglutide and tirzepatide filled a real gap during the 2022–2024 shortages, but the FDA has since declared both shortages resolved. That change sharply limits when compounding pharmacies may legally produce copies, and quality and dosing accuracy in compounded products have varied widely.

Some wellness clinics bundle these drugs with vitamin injections, and the lipo-c vs tirzepatide comparison you see in that marketing is not a like-for-like choice, since one is a wellness injection and the other is a prescription GLP-1 with measurable metabolic effects. Researchers also track pipeline candidates, and the cagrilintide vs tirzepatide question comes up often, but nothing in that class has an approved US price tag yet.

How to Lower Your Tirzepatide or Ozempic Bill

1. Ask your prescriber to submit a prior authorization with the strongest clinical documentation available.
2. Check the manufacturer savings card; Eli Lilly and Novo Nordisk both offer programs, though eligibility usually requires commercial insurance.
3. Compare the manufacturer's direct pharmacy against your local chain and a mail-order option.
4. Request a 90-day fill if your plan allows it, since the per-month cost is often lower.
5. Ask whether a lower maintenance dose or a preferred-tier brand would still meet your treatment goals.
6. Check whether your employer offers a weight-management or GLP-1 carve-out program with a capped copay.

Manufacturer savings cards generally cannot be combined with Medicare, Medicaid, or any federal healthcare program. That restriction is a common reason Medicare patients pay far more than commercial members for the identical prescription.

Cost is only one part of the decision. Both semaglutide and tirzepatide can cause nausea, vomiting, diarrhea, and, rarely, more serious complications such as pancreatitis or gallbladder disease. Talk with a licensed healthcare professional about whether either drug is appropriate for you, and confirm your actual out-of-pocket cost before you fill the first prescription.

COMMON QUESTIONS

Frequently Asked Questions

Is Ozempic cheaper than tirzepatide?

At list price the two are close, with Ozempic around $997 per month and Zepbound around $1,060 per month. Cash-pay programs have narrowed the gap further, and Zepbound vials at the lowest dose can cost less than Ozempic. What you actually pay depends on your plan's formulary and whether prior authorization is approved.

Does insurance cover tirzepatide or Ozempic for weight loss?

Ozempic is not FDA-approved for weight loss, so plans rarely cover it for that purpose. Zepbound and Wegovy are approved for chronic weight management, but coverage varies widely and often requires a BMI threshold, a related condition such as sleep apnea, or a step-therapy trial. Medicare Part D generally does not cover drugs used only for weight loss.

How much does tirzepatide cost without insurance?

Without insurance, Zepbound single-dose vials from the manufacturer's direct pharmacy have started around $349 to $499 per month depending on dose. Mounjaro pens typically run near $499 per month through the same type of cash-pay program. Retail list prices with no discount remain close to $1,000 per month.